Dupilumab in moderate‐to‐severe prurigo nodularis: Real‐world data from early access program
Qualified researchers may request access to patient-level data and related documents. The early access program (EAP) Protocol and the summary of the EAP report are available on the Healthcare authority website (https://www.has-sante.fr/). Patient-level data will be anonymized to protect the privacy of the EAP participants.
Authors
- J. Vanlerberghe
- M. Jachiet (ORCID: https://orcid.org/0000-0001-5286-9689)
- M. Samimi
- Claudia Barbosa (ORCID: https://orcid.org/0000-0001-5478-3424)
- S. Osdoit
- Carine Véra
- Emmanuelle Amazan (ORCID: https://orcid.org/0009-0002-6650-2743)
- Jean‐David Bouaziz (ORCID: https://orcid.org/0000-0002-4993-2461)
- Simmi Wiggins (ORCID: https://orcid.org/0009-0006-2880-1995)
- Cédric Meyer
- Laurent Misery
- C. Toussaint
- Pierre‐André Bécherel
- Véronique Marcadé Fulcrand
- Valérie Dorizy‐Vuong
Institutions
- Université de Tours (FR)
- Université Paris Cité (FR)
- Saint Louis University Hospital (US)
- Sanofi (France) (FR)
- Lille’s Cardiology Hospital (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Bordeaux Population Health (FR)
- Hôpital Saint-André (FR)
- Anton Proksch Institut (AT)
- Centre Hospitalier Régional Universitaire de Brest (FR)
- Centre Hospitalier Universitaire de Martinique (MQ)
- Hôpital Saint-Louis (FR)
- Sanofi (United Kingdom) (GB)
- Centre Hospitalier Saint-Nazaire (FR)
Publication Details
- Journal
- Journal of the European Academy of Dermatology and Venereology
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1111/jdv.70294
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00